Natural products and organocatalysis
Anchor (Master): Nicolaou, K. C. & Sorensen, E. J. — Classics in Total Synthesis (VCH, 1996); Berkessel & Groger — Asymmetric Organocatalysis (Wiley-VCH, 2005); MacMillan, D. W. C. — Nature 455, 304 (2008) review
Intuition Beginner
Nature is the world's best synthetic chemist. A single cell builds morphine, cholesterol, penicillin, and the scent of a lemon from carbon dioxide, water, and sunlight — no high temperatures, no toxic solvents, no protecting groups. These molecules, made by living organisms, are natural products. Chemists study them for two reasons: many are medicines, and the way nature assembles them teaches us how to build molecules more efficiently in the laboratory.
The strategy nature uses is biosynthesis. A small set of simple building blocks — acetic acid, an amino acid or two, and a five-carbon unit called isoprene — is stitched together by enzymes along a few repeating pathways. The mevalonate pathway chains isoprene units head-to-tail to build every terpene, from the fragrance of citrus to the backbone of cholesterol. The chemist's response is biomimetic synthesis: copy nature's disconnections and let biology suggest the shortest route.
Organocatalysis is a parallel idea in the laboratory. Instead of an enzyme or a metal, a small organic molecule — usually built from an amino acid — acts as the catalyst. It binds briefly to the reacting molecule, guides the reaction to one stereochemical outcome, and is released. Proline, a chiral amino acid, catalyses an asymmetric aldol reaction with no metal at all. This shared logic — borrow nature's strategies, then borrow nature's catalysts — is the bridge between biosynthesis and modern synthesis.
Visual Beginner
Picture biosynthesis as an assembly line. Simple acetic-acid and sugar-derived units enter at one end; enzymes stitch them together in a fixed order; complex molecules exit at the other. The image shows two lines: the mevalonate line that feeds every terpene, and the organocatalysis line where a chiral amine catalyst (proline) does the job an enzyme would do.
The terpene classes are classified by how many isoprene units they contain:
| Terpene class | Carbons | Isoprene units | Representative |
|---|---|---|---|
| Hemiterpene | 1 | Isoprene (plant emissions) | |
| Monoterpene | 2 | Limonene (citrus scent) | |
| Sesquiterpene | 3 | Farnesene; artemisinin precursor | |
| Diterpene | 4 | Taxadiene (taxol precursor) | |
| Triterpene | 6 | Squalene, then cholesterol | |
| Tetraterpene | 8 | -Carotene |
Worked example Beginner
Limonene, the scent of lemons, is a monoterpene. Show how the citrus cell builds it from two five-carbon units.
Step 1. The two building blocks. The cell makes isopentenyl pyrophosphate (IPP) and its isomer dimethylallyl pyrophosphate (DMAPP) from acetic acid through the mevalonate pathway. Both are units (five carbons plus a pyrophosphate leaving group).
Step 2. Head-to-tail coupling. The enzyme prenyl transferase joins IPP and DMAPP. The tail carbon of DMAPP (C4) links to the head carbon of IPP (C1), and the pyrophosphate leaves. The product is geranyl pyrophosphate (GPP). Carbon count check: . GPP is a chain.
Step 3. Cyclisation. A monoterpene cyclase folds GPP into the right shape and closes a six-membered ring, expelling the remaining pyrophosphate. The product is limonene, molecular formula , with one six-membered ring and one double bond.
What this tells us: a natural product is built by coupling two isoprene units head-to-tail and then cyclising. The whole sequence runs in water at room temperature, catalysed by two enzymes.
Check your understanding Beginner
Formal definition Intermediate+
A natural product is an organic compound produced by a living organism — a microbe, plant, animal, or fungus — that is not directly involved in the organism's primary growth, reproduction, or energy metabolism. Natural products are secondary metabolites, distinguished from the primary metabolites (the twenty proteinogenic amino acids, the nucleotides, acetyl-CoA, glucose) that every cell needs to survive. The boundary is functional rather than strict: cholesterol is a primary membrane component yet is formally a triterpene natural product.
The secondary metabolites fall into a small number of structural families, each traceable to one of three biosynthetic pathways that convert primary metabolites into the molecular scaffolds of natural-product chemistry.
The acetate pathway (polyketides). Two-carbon acetic-acid units, activated as acetyl-CoA and malonyl-CoA, are condensed head-to-tail by polyketide synthase (PKS) modules. Each condensation releases and and extends the chain by two carbons. Repetition produces the polyketides: long oxygenated chains that cyclise into macrolide antibiotics (erythromycin, ), aromatic polyphenols (tetracycline), and the mycotoxins. The biosynthetic logic — Claisen condensation iterated with optional reduction — is the same as fatty-acid synthesis, which shares the acetate pathway.
The mevalonate pathway (terpenes and isoprenoids). Three acetyl-CoA molecules condense to hydroxymethylglutaryl-CoA (HMG-CoA), which is reduced to mevalonate, then phosphorylated and decarboxylated to the five-carbon isopentenyl pyrophosphate (IPP) and its isomer dimethylallyl pyrophosphate (DMAPP). Prenyl transferases chain IPP and DMAPP head-to-tail: GPP (), farnesyl pyrophosphate (), geranylgeranyl pyrophosphate (). Terpene cyclases fold and cyclise these linear precursors into the monoterpenes (limonene, pinene), sesquiterpenes (artemisinin's amorpha-4,11-diene precursor, ), diterpenes (taxadiene, ), and — after tail-to-tail coupling of two farnesyl chains — the triterpene squalene () that cyclises to lanosterol and is then trimmed to cholesterol (). The steroids (cholesterol, testosterone, cortisol, the bile acids) are all triterpene-derived; their four-ring fused skeleton is the cyclised squalene backbone with three methyl groups removed.
The shikimate pathway (aromatic amino acids and phenylpropanoids). Phosphoenolpyruvate (a glycolytic unit) and erythrose-4-phosphate (a pentose-phosphate unit) condense and cyclise, through seven enzyme-catalysed steps, to chorismate, the branch point for the aromatic amino acids phenylalanine, tyrosine, and tryptophan. Downstream, phenylalanine is deaminated to cinnamate, launching the phenylpropanoid pathway that produces lignin, flavonoids, and the tannins. The alkaloids — nitrogen-containing natural products such as morphine, caffeine, nicotine, quinine, and vinblastine — are biosynthesised principally from aromatic amino-acid precursors (tryptophan, tyrosine) by decarboxylation, methylation, and oxidative coupling, which installs the nitrogen and builds the heterocyclic ring systems characteristic of the class.
The isoprene (biogenetic) rule. Ruzicka's 1953 formalisation [Ruzicka 1953] of Wallach's 1887 isoprene rule [Wallach 1887] states that every isoprenoid is conceptually divisible into isopentenyl units joined head-to-tail. The rule predicts carbon counts ( for a linear -unit terpene), locates the gem-dimethyl branch points, and identifies the cyclisation points — making it a diagnostic and retrosynthetic tool, not merely a bookkeeping device.
Organocatalysis is the use of a substoichiometric, low-molecular-weight, metal-free organic compound as a chiral catalyst. The catalyst is turnover: it binds a substrate, accelerates the reaction with stereochemical control, and is released to bind another substrate molecule. Two activation manifolds dominate:
Enamine catalysis. A chiral secondary amine (typically proline) condenses with a ketone or aldehyde to form an enamine, raising the HOMO of the carbonyl carbon and rendering it nucleophilic. The chiral backbone of the amine shields one face of the enamine, so alkylation, aldol, or Mannich reaction at the other face proceeds with high enantioselectivity. Hydrolysis regenerates the catalyst.
Iminium catalysis. A chiral secondary amine condenses with an -unsaturated aldehyde to form an iminium ion, lowering the LUMO of the conjugated system and activating it toward nucleophilic attack. The chiral amine shields one -face; the nucleophile (an indole, a silyl enol ether, a malonate) attacks the exposed face with high enantioselectivity.
The quantitative metrics are enantiomeric excess and diastereomeric ratio . A modern asymmetric organocatalytic reaction routinely achieves .
Counterexamples to common slips
"Organocatalysts are weaker than metal catalysts and therefore inferior." The absence of a metal is not a weakness but a difference in activation manifold. Enamine catalysis activates the carbonyl carbon as a nucleophile (umpolung), a transformation no Lewis-acid metal catalyst achieves. The two classes are complementary, not ranked.
"Biosynthesis and laboratory synthesis compete." They inform each other. The mevalonate pathway suggests the head-to-tail disconnection a synthetic chemist uses; the laboratory aldol suggests the enzyme mechanism a biochemist proposes. Biomimetic synthesis is the explicit merger.
"All natural products come from plants." The largest and most medicinally important class — the polyketide antibiotics — comes from soil bacteria (Streptomyces). Marine invertebrates, fungi, and insects contribute equally distinctive scaffolds (trabectedin, penicillin, cantharidin).
"The isoprene rule fails for irregular terpenes." The rule predicts regular head-to-tail coupling. The irregular terpenes (lavandulyl, chrysanthemyl) arise from head-to-middle or tail-to-tail coupling and are diagnosed as exceptions that confirm the rule's predictive force for the regular majority.
Key mechanism Intermediate+
Two mechanisms define modern organocatalysis: the Hajos-Parrish proline-catalysed enamine aldol (the founding asymmetric organocatalytic C-C bond formation) and the MacMillan iminium activation manifold. Together they show how a small chiral amine, with no metal, controls stereochemistry as tightly as an enzyme.
The Hajos-Parrish enamine Robinson annulation
In 1974, Hajos and Parrish reported [Hajos-Parrish 1974] that -proline at 3 mol% catalyses the intramolecular aldol condensation of a symmetrical triketone, giving the Wieland-Miescher ketone (a steroid precursor) in 100% yield and 93% ee after dehydration to the enone. This was the first catalytic, asymmetric, metal-free C-C bond-forming reaction; for two decades it remained an isolated curiosity until List, Lerner, and Barbas generalised it in 2000 [List 2000].
The mechanism proceeds through three stages.
Enamine formation. The secondary amine of -proline condenses with the ketone carbonyl, losing water, to give an enamine. The carbonyl carbon, previously electrophilic, is now part of a nucleophilic enamine — an umpolung (polarity inversion) of the carbonyl's native reactivity.
Intramolecular aldol via a chiral transition state. The proline carboxylate donates a hydrogen bond to the accepting ketone carbonyl, organising a Zimmerman-Traxler-like chair transition state. In this geometry, only one enamine face is exposed to the acceptor; the other is blocked by the pyrrolidine ring. C-C bond formation occurs from the exposed face, setting the new stereocentre. This is the List-Houk model [List 2000], in which the bifunctional acid-base character of proline (amine plus carboxylic acid in one molecule) is the stereochemical controller.
Catalyst turnover. Hydrolysis of the iminium-product intermediate releases the aldol adduct and regenerates free proline, which enters the next cycle. The net reaction is an intramolecular aldol with 93% ee; subsequent dehydration gives the Robinson annulation enone product.
The mechanistic point is that proline does simultaneously what a metal catalyst and a chiral ligand do separately: it activates the nucleophile (enamine formation) and it imposes stereochemistry (the carboxylate-directed transition state). The catalyst is recovered because every step is reversible under the aqueous-acidic conditions.
MacMillan iminium catalysis
MacMillan's 2000 iminium strategy [MacMillan 2000] addresses the complementary problem: activating an -unsaturated aldehyde toward nucleophilic attack. A chiral imidazolidinone condenses with the enal to form an iminium ion, lowering the substrate LUMO and accelerating conjugate addition. The bulky chiral amine shields the face of the iminium; the nucleophile (an indole in the Friedel-Crafts alkylation, a silyl enol ether in the Michael addition) attacks the exposed face. ee values of 90-97% are routine across more than a dozen nucleophile classes.
The two manifolds are stereochemically mirror-image in their logic: enamine catalysis makes a carbonyl-derived carbon nucleophilic and controls which face of that nucleophile reacts; iminium catalysis makes a carbonyl-derived carbon electrophilic and controls which face the nucleophile approaches. Both turn over because condensation and hydrolysis are reversible.
Bridge. The enamine and iminium activation builds toward 15.10.01 retrosynthetic analysis, where a biomimetic disconnection treats an aldol product as the trace of a proline-catalysed step rather than a stoichiometric enolate equivalent. This is exactly the umpolung logic that generalises carbonyl reactivity: an enamine makes the carbonyl carbon nucleophilic, inverting the polarity that governs electrophilic addition in 15.07.01 carbonyl chemistry. The foundational reason proline is dual to an aldolase enzyme is that both present a chiral amine and a Brønsted-acid hydrogen-bond donor in a single scaffold — the central insight that appears again in 15.12.01 amino-acid chemistry, where the same pyrrolidine ring of proline shapes protein tertiary structure. Putting these together, the bridge is that organocatalysis lets the laboratory recapitulate the stereochemical control of an enzyme without the enzyme's molecular weight, and the strategy generalises to cascade and photoredox organocatalysis covered below.
Exercises Intermediate+
Lean formalization Intermediate+
This unit ships with lean_status: none. Mathlib has no representation of organic biosynthetic pathways (mevalonate, acetate, shikimate) as enzymatic graph-rewrite cascades, no notion of enamine or iminium activation as a polarity-inverting transformation on a carbonyl carbon, and no measurable type for enantiomeric excess over a product distribution. The List-Houk transition-state model — a geometric prediction of the major enantiomer from a chiral secondary-amine scaffold — has no formal counterpart. Formalising organic reaction mechanism in a proof assistant first requires a computational molecular-graph representation with bond order, stereochemistry, and charge, which Mathlib does not provide. The correctness gate for this material is human review of the mechanism and the cited primary literature, not Lean.
Advanced results Master
Three modern developments connect organocatalysis, biosynthesis, and total synthesis into a single research frontier: the expansion of organocatalysis beyond enamine and iminium into radical and photoredox manifolds; the rational engineering of biosynthetic pathways to produce natural products in microbial hosts; and the strategic use of organocatalytic steps inside landmark total syntheses.
SOMO and photoredox organocatalysis
MacMillan's group extended enamine catalysis into single-electron territory. In SOMO (singly occupied molecular orbital) catalysis, an enamine intermediate is oxidised by a stoichiometric single-electron oxidant (e.g., ceric ammonium nitrate) to a three-electron radical cation. This radical couples with a second radical or adds to an alkene in an enantioselective -functionalisation of aldehydes — a transformation no polar enamine achieves. The chiral imidazolidinone catalyst controls which face of the radical cation reacts, giving ee values above 90%.
Photoredox organocatalysis merges a MacMillan imidazolidinone organocatalyst with a ruthenium or iridium photoredox catalyst and visible light. The photoredox catalyst, photoexcited, transfers a single electron to or from the iminium or enamine intermediate, generating a radical under mild conditions. The organocatalyst imposes enantiocontrol; the photoredox cycle provides the redox driving force. The combination enables asymmetric -alkylation of aldehydes with alkyl halides, asymmetric conjugate additions, and direct arene functionalisations that neither catalyst achieves alone. The 2021 Nobel Prize in Chemistry cited List and MacMillan for establishing organocatalysis as the third pillar of asymmetric catalysis alongside biocatalysis and transition-metal catalysis.
Engineered biosynthesis and combinatorial biosynthesis
The biosynthetic pathways are no longer only objects of study; they are engineering substrates. Polyketide synthase (PKS) modules are modular — each module adds one ketide unit and optionally reduces it — so swapping, deleting, or inserting modules produces "unnatural natural products" with predictable carbon skeletons. Leadlay, Khosla, and Walsh established [MacMillan 2008] the module-swapping logic that lets engineered Streptomyces produce 6-deoxyerythronolide B analogues inaccessible by chemical synthesis. Prenyl transferases and terpene cyclases have been similarly engineered: site-directed mutagenesis of a sesquiterpene cyclase active site changes the cyclisation product from one skeleton to another, producing new amorpha, germacrene, or cadinane frameworks from the same farnesyl pyrophosphate precursor. The engineered pathway is a programmable retrosynthesis: the biosynthetic route is the synthetic plan, executed in a fermenter.
Organocatalysis inside total synthesis
Several landmark syntheses use an organocatalytic step as the strategic enantioselective reaction. The Hong synthesis of oseltamivir (Tamiflu) uses a proline-derived catalyst in a triple cascade — three organocatalytic reactions in one flask — to build the cyclohexene core in high ee and high atom economy. The MacMillan synthesis of (+)-aspidophytine uses an iminium-catalysed Diels-Alder to set the single stereocentre that governs the entire alkaloid skeleton. List's synthesis of carbohydrates from two simple aldehydes uses a proline-catalysed aldol dimerisation followed by a second aldol, constructing the stereochemically dense sugar skeleton without protecting groups. These syntheses demonstrate that organocatalytic steps are not niche methodology but strategic disconnections capable of bearing the weight of a complex target.
The three catalytic modalities compared
| Modality | Catalyst | Best substrate | Selectivity ceiling | Operational burden |
|---|---|---|---|---|
| Organocatalysis | Proline, imidazolidinone | Carbonyls, enals | - | Low (air-stable, cheap) |
| Transition-metal | Pd, Ru, Rh, Ir complexes | Aryl halides, alkenes | - | Moderate (degassing, ligand cost) |
| Biocatalysis | Engineered enzymes | Complex polyfunctional | ; single diastereomer | High (water, narrow , ) |
The three are complementary. A modern synthesis may use an organocatalytic aldol to set the first stereocentre, a palladium-catalysed Suzuki to join two fragments, and an engineered ketoreductase to set a late-stage alcohol stereocentre — each modality chosen for the transformation it uniquely enables.
Synthesis. Organocatalysis, transition-metal catalysis, and biocatalysis are three instantiations of the same abstract problem — lowering the activation barrier of a bond-forming step while controlling its stereochemistry — and the foundational reason each dominates a different substrate class is that their activation manifolds are complementary. This is exactly the complementarity that appears again in 15.09.01 organometallic chemistry, where a palladium centre activates an aryl halide that no enamine can touch, and in 15.07.01 carbonyl chemistry, where the metal-catalysed and organocatalysed aldol cover different electrophile scopes. Putting these together with the biosynthetic logic of the mevalonate, acetate, and shikimate pathways, the central insight is that every total synthesis is a competition between biomimetic and ab initio strategies, and the bridge is that nature's enzymes and the chemist's small-molecule catalysts are conceptually interchangeable enantioselective machines. The field generalises to cascade and photoredox organocatalysis, where single-flask sequences rival the step economy of a biosynthetic pathway, and the engineered biosynthesis of polyketides and terpenes closes the loop by making the living cell itself the synthetic apparatus.
Full proof set Master
Proposition (the head-to-tail rule for linear isoprenoids). Let denote an acyclic, regular isoprenoid assembled from isopentenyl () units by iterated head-to-tail prenyl transfer. Then (i) contains exactly carbon atoms; (ii) contains exactly inter-unit C-C bonds, each joining the tail carbon () of one unit to the head carbon () of its neighbour; (iii) the gem-dimethyl branch points occur at every fifth carbon along the main chain, so the skeleton is uniquely reconstructible from the head-to-tail rule.
Proof. By induction on , the number of isopentenyl units.
Base case (). is a single isopentenyl unit: five carbons ( through ) bearing the gem-dimethyl branch at . There are no inter-unit bonds () and a single branch point. Claims (i), (ii), (iii) hold.
Inductive step. Assume the claim holds for . A prenyl transferase appends one further IPP unit to by head-to-tail condensation: the tail carbon of the incoming unit forms a new C-C bond to the head carbon of a terminal unit of , with loss of pyrophosphate. The condensation adds five carbons (the incoming IPP unit contributes its skeleton; no carbon is lost, since the leaving group is pyrophosphate, not ). Hence , establishing (i). Exactly one new inter-unit bond forms, so the count increases from to , giving inter-unit bonds, establishing (ii). The new unit contributes its gem-dimethyl branch at its own , located five carbons beyond the previous branch point along the extended chain, so the branch points remain five carbons apart, establishing (iii). By induction the claim holds for all .
Corollary (squalene and cholesterol). Squalene, the precursor of all steroids, is a regular tail-to-tail dimer of two farnesyl () units. By the proposition with , each farnesyl half contains carbons and two head-to-tail junctions; the tail-to-tail joining adds a central non-head-to-tail bond, giving squalene's skeleton with five head-to-tail junctions and one tail-to-tail junction. Enzymatic cyclisation of squalene to lanosterol () preserves the carbon count, and the subsequent demethylation removes three methyl groups () to give cholesterol (), accounting for the observed deficit between the triterpene precursor and the steroid product.
The proposition is diagnostic as well as descriptive: locating the gem-dimethyl branch points in an unknown isoprenoid identifies the head-to-tail junctions, which in turn reveals the prenyl-transfer order and constrains the biosynthetic gene cluster responsible for the natural product. The irregular terpenes (those with head-to-middle or head-to-head junctions) are the cases where the rule fails, and their identification is itself diagnostic of a non-standard prenyl transferase.
Connections Master
Carbonyl chemistry — nucleophilic addition
15.07.01. Enamine catalysis is an umpolung of carbonyl reactivity: the carbonyl carbon, electrophilic in nucleophilic addition, becomes nucleophilic when proline converts it to an enamine. Every organocatalytic aldol, Mannich, and Michael reaction is a carbonyl reaction run in reverse polarity, and the Felkin-Anh and Zimmerman-Traxler transition-state models that govern classical carbonyl stereochemistry reappear unchanged as the stereochemical controllers of the organocatalytic versions.Organometallic synthesis
15.09.01. Transition-metal and organocatalytic methods are complementary rather than competing. Palladium-catalysed cross-coupling, olefin metathesis, and asymmetric hydrogenation activate substrates (aryl halides, alkenes, prochiral ketones) that no enamine or iminium can touch; organocatalysis activates carbonyl carbons in umpolung mode that no Lewis-acid metal centre achieves. A modern total synthesis routinely combines both, choosing each for the transformation it uniquely enables.Retrosynthetic analysis
15.10.01. Biomimetic synthesis applies biosynthetic logic as a retrosynthetic strategy. Robinson's 1917 tropinone synthesis — a one-pot double Mannich reaction that builds the tropane skeleton from succinaldehyde, methylamine, and acetone dicarboxylate — is the founding example: the laboratory disconnection mirrors the biosynthetic one, and the forward reaction runs in water at room temperature. The isoprene rule similarly prescribes the head-to-tail disconnections of any terpene target.Amino acids and protein chemistry
15.12.01. Proline, the founding organocatalyst, is itself a proteinogenic amino acid, and the class-I aldolases share proline's bifunctional acid-base motif (a lysine amine plus an active-site acid). The stereochemical control that a five-membered pyrrolidine ring exerts in the small-molecule catalyst is the same control that the enzyme's active site exerts in nature — the smallest case of biomimetic catalyst design.Nucleic acid chemistry
15.13.01. The biosynthetic pathways are encoded in DNA: the mevalonate-pathway enzymes are gene products, the polyketide synthase modules are encoded by modular gene clusters, and engineered biosynthesis edits these genes to reprogram natural-product synthesis. The bridge from DNA sequence to natural-product structure runs through the enzymatic graph-rewrite cascades formalised in the acetate, mevalonate, and shikimate pathways.
Historical and philosophical context Master
The structural study of natural products began with the isolation of the alkaloids in the early nineteenth century (morphine, 1804; quinine, 1820) and the recognition that these nitrogen-containing plant compounds possess complex, stereochemically rich skeletons. Otto Wallach's systematic investigation of the terpene essential oils led him in 1887 to formulate the isoprene rule, the observation that every terpene is formally divisible into five-carbon isopentenyl units [Wallach 1887]; he received the Nobel Prize in Chemistry in 1910 for this work. Leopold Ruzicka extended the rule into the biogenetic isoprene rule [Ruzicka 1953], which proposed that the carbon skeletons of terpenes arise from enzymatic coupling and cyclisation of isopentenyl precursors — a hypothesis that predicted the existence of the prenyl transferases and terpene cyclases two decades before they were isolated. Ruzicka received the Nobel Prize in 1939.
The biomimetic principle in synthesis was established by Robert Robinson's 1917 tropinone synthesis [Robinson 1917]. Robinson recognised that the tropane skeleton of the alkaloid tropinone could be assembled in a single step from succinaldehyde, methylamine, and acetone dicarboxylate by a double Mannich reaction — the same disconnection that the biosynthetic enzyme catalyses. The synthesis ran in water at room temperature in a single flask, and its elegance became the standard against which biomimetic syntheses are measured.
Asymmetric organocatalysis was discovered twice before it was recognised as a field. Hajos and Parrish reported in 1974 [Hajos-Parrish 1974] that -proline catalyses an intramolecular aldol condensation in 93% ee — the first catalytic asymmetric organocatalytic C-C bond formation — but the result was treated as an industrial curiosity rather than a general method. Benjamin List, David MacMillan, and their collaborators independently established in 2000 that proline enamine catalysis [List 2000] and imidazolidinone iminium catalysis [MacMillan 2000] constitute general, metal-free asymmetric catalytic manifolds. List and MacMillan shared the 2021 Nobel Prize in Chemistry for "the development of asymmetric organocatalysis," the citation naming organocatalysis as the third pillar of asymmetric synthesis alongside biocatalysis and transition-metal catalysis.
Bibliography Master
@article{Wallach1887,
author = {Wallach, O.},
title = {Zur Kenntnis der Terpene und der {\"a}therischen {\"O}le},
journal = {Liebigs Ann. Chem.},
volume = {239},
pages = {1--53},
year = {1887}
}
@article{Ruzicka1953,
author = {Ruzicka, L.},
title = {The Isoprene Rule and the Biogenesis of Terpenic Compounds},
journal = {Experientia},
volume = {9},
pages = {357--367},
year = {1953}
}
@article{Robinson1917,
author = {Robinson, R.},
title = {A Synthesis of Tropinone},
journal = {J. Chem. Soc., Trans.},
volume = {111},
pages = {762--768},
year = {1917}
}
@article{HajosParrish1974,
author = {Hajos, Z. G. and Parrish, D. R.},
title = {Asymmetric Synthesis of Bicyclic Intermediates of Natural Product Chemistry},
journal = {J. Org. Chem.},
volume = {39},
pages = {1615--1621},
year = {1974}
}
@article{List2000,
author = {List, B. and Lerner, R. A. and Barbas, C. F.},
title = {Proline-Catalyzed Direct Asymmetric Aldol Reactions},
journal = {J. Am. Chem. Soc.},
volume = {122},
pages = {2395--2396},
year = {2000}
}
@article{MacMillan2000,
author = {Ahrendt, K. A. and Williams, C. J. and MacMillan, D. W. C.},
title = {A New Strategy for Organic Catalysis: The Direct and Enantioselective Activation of Diels-Alder Reactions via Iminium Catalysis},
journal = {J. Am. Chem. Soc.},
volume = {122},
pages = {4243--4244},
year = {2000}
}
@article{MacMillan2008,
author = {MacMillan, D. W. C.},
title = {The Advent and Development of Organocatalysis},
journal = {Nature},
volume = {455},
pages = {304--308},
year = {2008}
}
@book{NicolaouSorensen1996,
author = {Nicolaou, K. C. and Sorensen, E. J.},
title = {Classics in Total Synthesis},
publisher = {VCH},
address = {Weinheim},
year = {1996}
}
@book{BerkesselGroger2005,
author = {Berkessel, A. and Groger, H.},
title = {Asymmetric Organocatalysis},
publisher = {Wiley-VCH},
address = {Weinheim},
year = {2005}
}
@book{Clayden2012,
author = {Clayden, J. and Greeves, N. and Warren, S.},
title = {Organic Chemistry},
edition = {2nd},
publisher = {Oxford University Press},
address = {Oxford},
year = {2012}
}